GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chromocell Therapeutics Corp (AMEX:CHRO) » Definitions » Forward Dividend Yield %

CHRO (Chromocell Therapeutics) Forward Dividend Yield % : 0.00% (As of Sep. 24, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Chromocell Therapeutics Forward Dividend Yield %?

As of today (2024-09-24), the Forward Annual Dividend Yield of Chromocell Therapeutics is 0.00%.

As of today (2024-09-24), the Trailing Annual Dividend Yield of Chromocell Therapeutics is 0.00%.

CHRO's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.575
* Ranked among companies with meaningful Forward Dividend Yield % only.

Chromocell Therapeutics's Dividends per Share for the three months ended in Jun. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Chromocell Therapeutics's Forward Dividend Yield %

For the Biotechnology subindustry, Chromocell Therapeutics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chromocell Therapeutics's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chromocell Therapeutics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Chromocell Therapeutics's Forward Dividend Yield % falls into.



Chromocell Therapeutics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Chromocell Therapeutics  (AMEX:CHRO) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Chromocell Therapeutics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Chromocell Therapeutics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chromocell Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Chromocell Therapeutics Corp is a clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as "NaV1.7", as well as other receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology.

Chromocell Therapeutics Headlines

From GuruFocus

Chromocell Announces Stock Repurchase Plan

By Marketwired 08-07-2024